Position in ARGX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,218,570
-$4,626,217 QoQ
Shares Held
4,547
-62.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#156
of 504 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,473,308 across 466 Biotechnology names. ARGX ranks #1 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,218,570 | 4,547 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $8,844,787 | 12,112 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $12,843,827 | 15,273 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $10,217,418 | 13,853 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,660,043 | 19,339 | Shares | Other | 2025-08-15 | |
| 2025-03-31 | $3,198,438 | 5,404 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $341,325 | 555 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $520,396 | 960 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $493,255 | 1,147 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $63,782 | 162 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $377,385 | 992 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $448,858 | 913 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $1,089,684 | 2,796 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $99,850 | 268 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $229,570 | 606 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $469,908 | 1,331 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $689,940 | 1,821 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $566,927 | 1,798 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $405,168 | 1,157 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $522,158 | 1,729 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $1,064,583 | 3,536 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $155,319 | 564 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $125,282 | 426 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $101,857 | 388 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $173,426 | 770 | Shares | Other | 2020-08-13 | |
| 2020-03-31 | $148,986 | 1,131 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||